Media - published on 20 Feb 2021

COVID-19 has shown how Big Pharma is broken

Charlotte Kilpatrick of Salon writes about the motives that pharmaceutical companies have to invest in R&D for underfunded global health threats, such as coronaviruses.

Get in touch

Back to top |